Literature DB >> 15278363

Inhibition of melanoma metastases by fenofibrate.

Maja Grabacka1, Wojciech Placha, Przemyslaw M Plonka, Stanislawa Pajak, Krystyna Urbanska, Piotr Laidler, Andrzej Slominski.   

Abstract

The effect of fenofibrate, a ligand of peroxisome proliferator-activated receptor (PPAR) alpha, on the growth and metastatic potential of Bomirski hamster melanoma s.c. tumors, pigmented line (BHM Ma) was investigated in vivo. RT-PCR and Western-blot analyses revealed the presence of mRNA and protein of PPAR alpha in BHM Ma cells. The animals treated orally with fenofibrate developed significantly fewer metastatic foci in the lungs, as compared to the control group; however, primary tumor growth remained unaltered. This observation is interesting in respect of the potential use of fenofibrate in melanoma chemoprevention. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15278363     DOI: 10.1007/s00403-004-0479-y

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  39 in total

1.  The peroxisomal proliferator-activated receptor (PPAR) α agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment.

Authors:  Dana Greene-Schloesser; Valerie Payne; Ann M Peiffer; Fang-Chi Hsu; David R Riddle; Weiling Zhao; Michael D Chan; Linda Metheny-Barlow; Mike E Robbins
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

2.  Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.

Authors:  M Grabacka; P Waligorski; A Zapata; D A Blake; D Wyczechowska; A Wilk; M Rutkowska; H Vashistha; R Ayyala; T Ponnusamy; V T John; F Culicchia; A Wisniewska-Becker; K Reiss
Journal:  J Physiol Pharmacol       Date:  2015-04       Impact factor: 3.011

3.  Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27 kip pathway in human glioblastoma cells.

Authors:  Dong-feng Han; Jun-xia Zhang; Wen-jin Wei; Tao Tao; Qi Hu; Ying-yi Wang; Xie-feng Wang; Ning Liu; Yong-ping You
Journal:  Tumour Biol       Date:  2015-01-08

4.  Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro.

Authors:  Anna Wilk; Katarzyna Urbanska; Maja Grabacka; Jennifer Mullinax; Cezary Marcinkiewicz; David Impastato; John J Estrada; Krzysztof Reiss
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

5.  Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.

Authors:  Pit Sertznig; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

6.  Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.

Authors:  Anna Wilk; Dorota Wyczechowska; Adriana Zapata; Matthew Dean; Jennifer Mullinax; Luis Marrero; Christopher Parsons; Francesca Peruzzi; Frank Culicchia; Augusto Ochoa; Maja Grabacka; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

7.  Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells.

Authors:  Jundong Zhou; Shuyu Zhang; Jing Xue; Jori Avery; Jinchang Wu; Stuart E Lind; Wei-Qun Ding
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

8.  PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.

Authors:  Maja Grabacka; Wojciech Placha; Krystyna Urbanska; Piotr Laidler; Przemysław M Płonka; Krzysztof Reiss
Journal:  Pigment Cell Melanoma Res       Date:  2008-04-26       Impact factor: 4.693

9.  Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway.

Authors:  Lulu Chen; Jin Peng; You Wang; Huangang Jiang; Wenbo Wang; Jing Dai; Meng Tang; Yan Wei; Hao Kuang; Guozeng Xu; Hui Xu; Fuxiang Zhou
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

10.  PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.

Authors:  Jean-François Michiels; Christophe Perrin; Nathalie Leccia; Daniela Massi; Paul Grimaldi; Nicole Wagner
Journal:  Pflugers Arch       Date:  2010-01-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.